test Browse by Author Names Browse by Titles of Works Browse by Subjects of Works Browse by Issue Dates of Works

Advanced Search
& Collections
Issue Date   
Sign on to:   
Receive email
My Account
authorized users
Edit Profile   
About T-Space   

T-Space at The University of Toronto Libraries >
University of Toronto at Scarborough >
Bioline International Legacy Collection >
Bioline International Legacy Collection >

Please use this identifier to cite or link to this item: http://hdl.handle.net/1807/23425

Title: Taxation concession for R&D - A viable option?
Issue Date: 31-Dec-1996
Publisher: AusBiotech
Citation: Australasian Biotechnology (backfiles) (ISSN: 1036-7128) Vol 6 Num 6
Abstract: Australasian Biotechnology, Volume 6 Number 6, November/December 1996, pp.358-359 Taxation concession for R&D - A viable option? David Conley, The Fourth Wave (Australia) Pty Ltd, Sydney NSW Code Number: AU96024 Size of Files: Text: 8.1K Graphics: Line drawing (gif) -3.1K So, is it? Many companies believe that it is now much harder to get a Taxation Concession for their R&D activities and are asking if it is still worth making an application. Government Incentive consultants, The Fourth Wave, say a definite "Yes". The concessional rate has been reduced from 150% to 125% effective 20 August 1996. The scheme as a whole is under closer scrutiny by the administering government department but in reality there has been little substantive change to the principles underlying the main scheme. Copyright 1996 Australian Biotechnology Association Ltd.
URI: http://hdl.handle.net/1807/23425
Other Identifiers: http://www.bioline.org.br/abstract?id=au96024
Rights: Copyright 1996 AusBiotech
Appears in Collections:Bioline International Legacy Collection

Files in This Item:

File Description SizeFormat
au96024.html11.02 kBHTMLView/Open

Items in T-Space are protected by copyright, with all rights reserved, unless otherwise indicated.